74397-12-9
74397-12-9 結(jié)構(gòu)式
基本信息
利馬前列
利馬前列素
(2E,11Α,13E,15S,17S)-11,15-二羥基-17,20-二甲基-9-氧代前列-2,13-二烯-1-酸(2E,11Α,13E,15S,17S)-11,15-DIHYDROXY-17,20-DIMETHYL-9-OXOPROSTA-2,13-DIEN-1-OICACID
D02722
ono1206
LIMAPROST
n-1-oicacid
,13e,15s,17s)-
17A,20-DIMETHYL-D2-PGE1
17α,20-dimethyl-δ2-PGE1
17S,20-Dimethyl-trans-D2-PGE1
17S,20-DiMethyl-trans-Δ2-PGE1
物理化學性質(zhì)
安全數(shù)據(jù)
制備方法
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2024/11/08 | HY-B0683 | 利馬前列素 Limaprost | 74397-12-9 | 2mg | 1200元 |
| 2024/11/08 | HY-B0683 | 利馬前列素 Limaprost | 74397-12-9 | 10mM * 1mLin DMSO | 1993元 |
| 2024/11/08 | HY-B0683 | 利馬前列素 Limaprost | 74397-12-9 | 5mg | 2381元 |
常見問題列表
Limaprost inhibits the IL-1-mediated induction of nerve growth factor (NGF) in a concentration-dependent manner with an IC 50 value of 70.9 ?nM human IVD cells.
Limaprost (OP1206) given orally at more than 100 mg/kg relieves Argipressin-induced ST depression of rat electrocardiogram (ECG).
Intra-coronary injection of Limaprost (OP1206; 1-100 ng/kg) in dogs results in a remarkable increase of coronary blood flow without any influence on heart rate, blood pressure, myocardial oxygen consumption and redox potential.
Resistance in both large and small vessels of dog coronary artery is decreased by intravenous injection of Limaprost (OP1206; 1-3 mg/kg).
Platelet aggregation, adhesiveness, bleeding time, and thrombocytopenia induced by ADP and collagen infusion in guinea-pigs are inhibited by oral administration of Limaprost (OP1206) at the same doses or doses less than those relieving Argipressin-induced ST depression of ECG.